186 related articles for article (PubMed ID: 22194042)
1. Tissue-specific responses to loss of transglutaminase 2.
Deasey S; Shanmugasundaram S; Nurminskaya M
Amino Acids; 2013 Jan; 44(1):179-87. PubMed ID: 22194042
[TBL] [Abstract][Full Text] [Related]
2. FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.
Tarantino U; Oliva F; Taurisano G; Orlandi A; Pietroni V; Candi E; Melino G; Maffulli N
Amino Acids; 2009 Apr; 36(4):679-84. PubMed ID: 18594942
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
[TBL] [Abstract][Full Text] [Related]
4. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA
J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540
[TBL] [Abstract][Full Text] [Related]
5. Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.
Johnson KA; Rose DM; Terkeltaub RA
J Cell Sci; 2008 Jul; 121(Pt 13):2256-64. PubMed ID: 18544639
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.
Johnson KA; Polewski M; Terkeltaub RA
Circ Res; 2008 Mar; 102(5):529-37. PubMed ID: 18202319
[TBL] [Abstract][Full Text] [Related]
7. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
Colak G; Johnson GV
Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
[TBL] [Abstract][Full Text] [Related]
8. Characterization of TG2 and TG1-TG2 double knock-out mouse epidermis.
Pitolli C; Pietroni V; Marekov L; Terrinoni A; Yamanishi K; Mazzanti C; Melino G; Candi E
Amino Acids; 2017 Mar; 49(3):635-642. PubMed ID: 27864691
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency.
Griffin KJ; Newell LM; Simpson KR; Beckers CML; Drinkhill MJ; Standeven KF; Cheah LT; Iismaa SE; Grant PJ; Jackson CL; Pease RJ
Atherosclerosis; 2020 Feb; 294():1-9. PubMed ID: 31874419
[TBL] [Abstract][Full Text] [Related]
11. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.
Cecil DL; Terkeltaub R
J Immunol; 2008 Jun; 180(12):8378-85. PubMed ID: 18523305
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase type II plays a protective role in hepatic injury.
Nardacci R; Lo Iacono O; Ciccosanti F; Falasca L; Addesso M; Amendola A; Antonucci G; Craxì A; Fimia GM; Iadevaia V; Melino G; Ruco L; Tocci G; Ippolito G; Piacentini M
Am J Pathol; 2003 Apr; 162(4):1293-303. PubMed ID: 12651621
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.
Nurminskaya M; Beazley KE; Smith EP; Belkin AM
J Vasc Res; 2014; 51(6):418-28. PubMed ID: 25612735
[TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.
Popov Y; Sverdlov DY; Sharma AK; Bhaskar KR; Li S; Freitag TL; Lee J; Dieterich W; Melino G; Schuppan D
Gastroenterology; 2011 May; 140(5):1642-52. PubMed ID: 21277850
[TBL] [Abstract][Full Text] [Related]
16. Glucose homeostasis in mice is transglutaminase 2 independent.
Iismaa SE; Aplin M; Holman S; Yiu TW; Jackson K; Burchfield JG; Mitchell CJ; O'Reilly L; Davenport A; Cantley J; Schmitz-Peiffer C; Biden TJ; Cooney GJ; Graham RM
PLoS One; 2013; 8(5):e63346. PubMed ID: 23717413
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase type II is involved in the pathogenesis of endotoxic shock.
Falasca L; Farrace MG; Rinaldi A; Tuosto L; Melino G; Piacentini M
J Immunol; 2008 Feb; 180(4):2616-24. PubMed ID: 18250473
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcification.
Beazley KE; Deasey S; Lima F; Nurminskaya MV
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):123-30. PubMed ID: 22034513
[TBL] [Abstract][Full Text] [Related]
19. Assessment of expression and specific activities of transglutaminases TG1, TG2, and FXIII-A during osteoclastogenesis.
Sun H; Kaartinen MT
Anal Biochem; 2020 Feb; 591():113512. PubMed ID: 31786225
[TBL] [Abstract][Full Text] [Related]
20. Intimal hyperplasia in loop-injured carotid arteries is attenuated in transglutaminase 2-null mice.
Min SK; Min SI; Jeong EM; Cho SY; Ha J; Kim SJ; Kim IG
J Korean Med Sci; 2014 Mar; 29(3):363-9. PubMed ID: 24616585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
